on M1 Kliniken AG (isin : DE000A0STSQ8)
M1 Kliniken AG Reports Significant Profit Growth in 2023
M1 Kliniken AG has announced a robust financial performance for 2023, with group sales increasing by 10.9% to €316.3 million. The beauty segment showed remarkable growth, with a 17.6% increase in sales to €70.8 million. The consolidated net profit after minority interests rose from €4.3 million to €10.3 million.
In response to this growth, the company proposed a dividend of €0.50 per share. The medium-term forecast for the beauty segment aims for sales between €200 and €300 million by 2029 and an EBIT margin of at least 20%.
The company aims to operate 150 to 200 specialist centers by 2029, expanding significantly from the current 58 locations. New markets, particularly in Eastern Europe, are targeted for future expansion.
The complete 2023 Annual Report is available for download on the M1 Kliniken AG website.
R. P.Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all M1 Kliniken AG news